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PeptideThe fundamental properties of ion channels assure their selectivity for a particular ion, its rapid permeation
through a central pore and that such electrical activity is modulated by factors that control the opening and
closing (gating) of the channel. All cell types possess ion channels and their regulated ﬂux of ions across the
membrane play critical roles in all steps of life. An ion channel does not act alone to control cell excitability but
rather forms part of larger protein complexes. The identiﬁcation of protein interaction partners of ion
channels and their inﬂuence on both the fundamental biophysical properties of the channel and its expression
in the membrane are revealing the many ways in which electrical activity may be regulated. Highlighted here
is the novel use of the patch clampmethod to dissect out the inﬂuence of protein interactions on the activity of
individual GABAA receptors. The studies demonstrate that ion conduction is a dynamic property of a channel
and that protein interactions in a cytoplasmic domain underlie the channel's ability to alter ion permeation. A
structural model describing a reorganisation of the conserved cytoplasmic gondola domain and the inﬂuence
of drugs on this process are presented.id type A receptor; MA helix,
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Ion channels provide a unique opportunity to observe protein
function in real time. The current passing through an individual ion
channel in a cell membrane may be recorded with continuous sub-
microsecond resolution, in situ by virtue of the patch clamp technique
[1]. Through themeticulous variation of experimental conditions such
recordings enable the fundamental properties of an ion channel to beelucidated. To date this technique has provided copious information
about the properties of ion selectivity, gating (the opening and closing
of an ion channel) and single-channel conductance (the ease with
which ions ﬂow) in numerous channel types. Most recently this
technique of patch clamping has been applied to study the dynamic
nature of protein–protein interactions that affect the activity of the
ligand-gated GABAA receptor [2]. This work is interpreted in light of
the structure and function of ligand-gated ion channels.
2. The GABAA ion channel
The GABAA receptor is a simple multi-subunit chloride-permeable
ionophore whose activity is controlled by the binding of two GABA
668 M.L. Tierney / Biochimica et Biophysica Acta 1808 (2011) 667–673molecules at extracellular inter-subunit sites [3]. However, the
receptor displays immense diversity in its biological function and
that diversity begins with the 19 different genes encoding an array of
subunits (α1–6, β1–3, γ1–3, δ, ε, π, θ, ρ1–3) that are potential
components of this heteromeric pentamer. As a general rule the
regulated assembly of two α isoforms, two β isoforms and a single γ
or δ subunit combine in the endoplasmic reticulum, with each
combination conferring some unique property on the physiology and
pharmacology of the ion channel [4]. Of the remaining subunits the ρ
isoforms appear unique in that they can form homo-pentamers and
are expressed predominantly in the retina [5] while little is known
about the functional role of neuronal GABAA receptors containing ε, π
or θ subunits. It is interesting to note, however, that π for example,
appears to be expressed in a number of peripheral tissues associated
with reproduction such as breast epithelial cells [6] and endometrium
[7]. This diversity imparted by receptor subtypes provides enormous
variety yet, interestingly, little is known about the regulatory signals
that drive their generation. Individual subunits share a common
architecture beginning with a large extracellular ligand domain,
followed by 4 transmembrane (TM) α-helices, which fold to form the
pore. Located between transmembrane domain 3 and 4 each subunit
contains a large intracellular loop (IL2 loop), which provides
numerous regulatory motifs and auxiliary protein binding sites that
are different in every subunit isoform (Fig. 1). Sequence comparison
reveals little homology and this region is also the target of splice
variants.
GABA is the only endogenous ligand for the GABAA receptor but
many endogenous (neurosteroids) and exogenous potentiators exist
including some major drug classes such as benzodiazepines, barbitu-
rates, general anaesthetics and alcohol. It has been proposed that the
major site of action for many of these drugs is the extrasynaptic
GABAA receptor populations (e.g., on the cell soma), and not those
found at synapses [8,9]. At the level of an individual channel such
potentiators increase the open probability of the channel through
changes in the open and closed time distributions (e.g., [10–13]). Such
drug-induced kinetic changes are not discussed further. In addition to
these kinetic changes, an increase in the single-channel conductance
is sometimes observed upon drug potentiation [2,14–19]. The
molecular mechanism by which dynamic variations in the GABAA
channel alter its permissiveness to Cl− ions, the structural rearrange-
ments in the channel that modulate the ion pathway and the way in
which drugs inﬂuence these processes are discussed in this review.
Understanding these molecular processes is fundamental if the
cellular signaling events that regulate and respond to this form of
relatively intense inhibitory signaling in the brain are to be elucidated.Fig. 1. Molecular architecture of GABAA receptors. A. Each subunit consists of a large extra
Situated within the lipid bilayer 4 transmembrane α-helices fold to form part of the ion con
loop between the 3rd and 4th transmembrane domains contains binding sites for auxiliary pr
helix at the C-terminal end of this loop is conserved in all subunits of ligand-gated ion chan
with the most common subunit combination found in the brain consisting of 2α, 2β and a
structure of the nicotinic acetylcholine receptor [32]. The 5 MA helices (one per subunit) fo2.1. All major drug classes increase the conductance of GABAA receptors
Traditionally, conductance has been viewed as an immutable
property of an ion channel and indeed, was used as one of the
distinguishing functional characteristics in single-channel recordings.
The observation that the benzodiazepine drug, diazepam, was able to
increase the single-channel conductance of native extrasynaptic
GABAA receptors implied otherwise, indeed that conductance was in
fact a dynamic property of the ion channel [14]. Subsequent studies
have revealed that all of the major drug classes known to potentiate
the GABA current are indeed able to increase the conductance of
native extrasynaptic receptors, thereby implying that this may be a
common mode of action of drugs and presumably, a general property
of all GABAA channel subtypes. For example, in the presence of sub-
threshold concentrations of GABA, general anaesthetics (e.g., etomi-
date [19], propofol [16]) barbiturates [15], neurosteroids (allopreg-
nanolone and alphaxalone) [20], and alcohol (ethanol, Fig. 2E and F
(Tierney, unpublished)) increase the Cl− current through GABAA
receptors by increasing both the frequency of channel openings (of an
individual channel as well as the number of channels opening) and
the single-channel conductance. The relatively long mean open time
of these larger conductance channels, the increased ion permeation
though an individual channel (N40 pS) and the increased likelihood of
multiple channels opening would ensure a sustained inhibitory
current as is necessary, for example, to maintain the tone and
regulate the excitability of the network [21–23]. The fact that all these
drug-binding events have a common molecular outcome, increased
conductance levels coupled with long mean open times, suggests that
despite binding at different sites on the receptor, the drugs affect a
common mechanism that underlies the increased permissiveness to
ion ﬂow.
2.2. Protein interactions alter the conductance through GABAA ion channels
Numerous proteins are known to bind to the different subunits of
pentameric GABAA receptors, thereby dictating their temporal and
spatial distribution in the membrane [24,25] as well as regulating the
movement of receptor subtypes into and out of their synaptic and
extrasynaptic neuronal locations under various physiological stimuli
[26–28]. Once in the membrane it appears that receptors are
constrained, i.e., their free diffusion in the lipid bilayer is prevented.
The GABAA receptor associated protein, GABARAP, is one protein that
facilitates this latter process. GABARAP trafﬁcs γ-containing GABAA
receptors from the endoplasmic reticulum to the plasma membrane
where such receptors are then able to form clusters both in neuronscellular N-terminal domain that contains ligand and well as some drug-binding sites.
duction pathway with transmembrane domain 2 lining the pore. The large intracellular
oteins as well as numerous post-translational modiﬁcation sites. The amphipathic (MA)
nels and it participates in protein binding events. B. The GABAA receptor is a pentamer
single γ subunit. C. 3-Dimensional model of the GABAA receptor based on the cryo-em
rm a ‘gondola’ structure directly beneath the permeation pore that spans the bilayer.
Fig. 2. Drug modulation of native GABAA channels. A. Single-channel recordings were performed in the inside-out patch conﬁguration thereby exposing the receptor's intracellular
MA helices to a stream of solution via gravity fed ﬂow tubes. Drugs and peptides were applied by the lateral movement of a ﬂow tube positioned to within 100 μm of the membrane
patch. No difference is observed when drugs are applied to the intracellular membrane as opposed to the external membrane (e.g., [14,53]). Currents were recorded from newborn
rat hippocampal neurons (Div8-15) at a membrane potential of−Vp=−60 mV. B. The current activated by 0.5 μM GABA shows a number of amplitudes, predominantly 0.85, 1.48
and 2.16 pA. C. Addition of 1 μMdiazepam caused an increase in both the open channel probability as illustrated by the presence of 2 channels (2 equally spaced peaks in the current
amplitude probability histogram) and in the average amplitude of the current to 4.5 pA (75 pS). D. In the continued presence of GABA and diazepam addition of the γMA peptide
(1 μM) caused a reduction in the current amplitude to ~1.2 pS and a reduced open probability (only one peak in the current amplitude probability histogram). Current amplitude
probability histograms on the right depict activity recorded over a longer period of 30 s. E. In another experiment exposure to 0.5 μM GABA produced a small amplitude current
(0.5 pA;−Vp=−60 mV). F. Addition of 1 mM ethanol to the patch caused an increase in both the open channel probability as shown by the presence of 3 channels (3 equally spaced
peaks in the current amplitude probability histogram) and in the average amplitude of the current to 4.25 pA (70 pS).
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quence of GABARAP co-expression, clustered recombinant GABAA
channels acquire additional biophysical properties. Signiﬁcantly, such
receptors are able to undergo transitions to high conductance states
upon diazepam potentiation [17,18], similar to that of native
extrasynaptic GABAA channels [14]. Identifying this correlation
between receptor clustering and enhanced ion permeation was
pivotal as it provided not only an important clue about the molecular
mechanism underlying conductance changes in GABAA channels but
also a means by which to test its existence. For example, for receptorsto remain clustered in the membrane they must be participating in
protein interactions that oppose their separation by diffusion.
Therefore if such protein interactions underlie the formation of high
conductance channels then it should be possible to reverse their
formation by disrupting the protein interactions that create them. A
commonly employed experimental approach aimed at disrupting
protein interactions is the use of competitor peptides. Such molecules
have been extensively used to characterize the function of the
targeted protein interactions at both a cellular and whole animal level
[31,32]. In contrast to all such earlier studies however, we have
670 M.L. Tierney / Biochimica et Biophysica Acta 1808 (2011) 667–673deﬁned a mechanism at the single molecule level by combining the
application of competitor peptides with single-channel recordings [2].
Uniquely, this experimental approach provides a remarkable visual
insight into the dynamic nature of protein–protein interactions that
affect the activity of a single ion channel as it occurs in real time.
Receptor–protein interactions have been identiﬁed in members of
the ligand-gated ion channel family. Many of them contribute to
receptor trafﬁcking and involve the conserved amphipathic intracel-
lular helix (MA helix) [30,33]. MA helices share no sequence
homology; however, the helical and chemical nature is conserved.
In GABAA receptors this MA helix motif in the single γ-subunit per
receptor interacts with either the trafﬁcking protein GABARAP
resulting in clustering of receptors, or with itself with unknown
physiological consequences. Because of the MA motif's predisposition
to form protein interactions we examined the ability of subunit-
speciﬁc competitor peptides, corresponding to each subunit's intra-
cellular amphipathic (MA) helix, to disrupt high conductance GABAA
channels. Currents were potentiated by the γ-subunit-speciﬁc drug
diazepam thereby deﬁning the receptor subtype responding and
peptides were applied directly onto the cytoplasmic side of mem-
brane patches while recording single-channel currents using the
inside-out patch conﬁguration (Fig. 2A).
Only the application of a peptide mimicking the MA helix of the γ2
subunit (γ381–403) of the GABAA receptor, and not that of the
α(371–393) or β(403–425) subunits, attenuated the potentiating effect
of diazepam on native receptors by substantially reducing their
conductance (Fig. 2B–D) [2]. Similarly, a reduction in conductance
was observed when diazepam was used to potentiate the GABA
current of a deﬁned receptor combination (α1β2γ2S) co-expressed
with GABARAP in L929 cells. The effect of the γ2 MA peptide,
however, was speciﬁc for clustered GABAA receptors able to undergo
transitions to high conductance states as it was ineffectual on diffusely
expressed recombinant αβγ receptors (i.e., expressed in the absence
of GABARAP) whose conductance never exceeds 40 pS [34,35].
Together, these data imply that the protein–protein interaction
competed by the γMA peptide involved an intermolecular interaction
mediated by the single γ-subunit per pentamer. Interestingly, in
patches displaying high conductance channels the action of the
peptide reduced conductance levels to unitary values (20–30 pS), that
is, those levels seen in diffusely expressed recombinant GABAA
receptors. One would predict the appearance of such levels if the
peptide was indeed preventing channels from interacting with each
other.
While the competitive action of the 23 residue γ2(381–403)
peptide clearly implicated the γMA helix as participating in an inter-
protein interaction it did not identify its interaction partner. Shorter
peptides capable of distinguishing between a γ2-GABARAP interac-
tion and a γ2–γ2 self interaction were therefore synthesized. A γ2
MA peptide lacking the N-terminal 5 amino acids (γ386–403) deﬁnes
the minimum sequence required to interact with GABARAP and is
effective in this capacity both in recombinant expression systems
[36] and in neurons [37,38]. Application of this γ2-C18 MA peptide
did not signiﬁcantly affect the conductance of recombinant αβγ
receptors co-expressed with GABARAP (Fig. 5A and B; [2]). To verify
that GABARAP was not the interaction partner, a peptide was tested
in which the last 5 amino acids were excluded (γ381–398; N18),
thereby removing the critical residues needed for a γ2-GABARAP
interaction. Application of this γ2 N18 MA peptide was still able to
reduce the conductance to unitary levels, albeit less effectively than
the full 23 residue peptide (Fig. 5C and D; [2]). Collectively, the data
support a mechanism whereby adjacent GABAA receptors interact
via their solitary γ2 subunit MA helices, altering ion permeation
through each channel (Fig. 4). The role of GABARAP in the process is
most likely as a trafﬁcking protein, targeting γ-containing receptors
to the membrane and facilitating (perhaps even regulating) their
inter-GABAA receptor interactions.2.3. Structural basis underlying conductance changes in the GABAA ion
channel
It has been proposed that all ligand-gated ion channels will share a
similar 3-dimensional structure and gating mechanism based on
sequence homology. The images derived from cryo-electron micros-
copy of tubular arrays of the Torpedo marmorata acetylcholine
receptor reveal what an individual ligand-gated ion channel looks
like in the closed state [39]. The only structure visible on the
cytoplasmic side of the receptor is that formed by the conserved MA
helices, one per subunit, which appear as a ‘hanging gondola’ beneath
the pore. The remaining N80% of this loop is unstructured under these
conditions [39]. Theoretically, the cytoplasmic gondola structure that
is positioned directly beneath the transmembrane pore-forming
domain (Fig. 3A, star) could physically impede ion ﬂow through the
channel and indeed it has been proposed that gaps visualised between
adjacent MA helices within an individual acetylcholine receptor, may
inﬂuence ion ﬂow in the acetylcholine receptor [39]. Consistent with
such a role, mutations within the MA helices of diffusely expressed
recombinant ligand-gated ion channels activated by acetylcholine,
5-hydroxytryptamine and glycine have all been shown to affect
single-channel conductance [40–42]. These mutational data indicate
that the MA helices are in a position to inﬂuence ion permeation
where it has been suggested that steric constraints imposed by intra-
receptor MA helices are responsible for conductance variability [42].
An extensionof the concept that thegondoladomainbeneath thepore
modulates ion permeation is that any structural perturbation that alters
this domain has the potential to also affect conductance. Furthermore, if
changes in channel conductance are achieved through the regulated
movement of the cytoplasmic gondola domain thenonemight expect this
domain to exhibit some modular ﬂexibility. Indeed, such ﬂexibility has
been demonstrated. Early electron microscopic images of negatively
stained tubular arrays of the acetylcholine receptor revealed the
distribution of the protein components that comprise the ion channel
that spans both sides of the lipid bilayer [43]. When viewed in transverse
sectionswhat is now known to be theMA helix-forming gondola domain
was seen to overlie the axial path of the channel beneath the lipid bilayer
(Fig. 3A). Equivalent images of tubes frozen in alkaline solution caused the
gondola domain to redistribute in an irregular way over the cytoplasmic
surface while the transmembrane and extracellular ligand-binding
domain retained their position in the crystal lattice (Fig. 3B).
Based on the predicted structural homology of ligand-gated ion
channels and the propensity of the 23 residue γ2MA peptide from the
GABAA receptor to form a helix (Fig. 3C) it seems reasonable to
suggest that the MA helices of GABAA receptors will form a similar
gondola structure as exists in the acetylcholine receptor. Thus protein
interactions involving the M3–M4 loop have the potential to alter the
disposition of theMA helices and therefore alter the gondola structure
beneath each pore. One possible explanation for the increase in
conductance observed in native GABAA receptors and clustered
recombinant receptors could be therefore, that physical interactions
between the γ2 subunits (involving residues 381–403) of adjacent
receptors provide the potential to alter the structural organization
beneath the pore (Fig. 4). Such an interpretation does not require the
‘co-ordinated opening’ of adjacent channel gates to account for high
conductance channels as suggested previously [14,17]. However,
changes in the gating kinetics of an individual channel could be
expected to accompany transitions to high conductance states if such
a domain acts as an interdependent gate similar to that described for
KirBac channels [44]. While such kinetic analysis have yet to be
completed it is interesting to note that the gating behaviour of
recombinant αβγ GABAA channels expressed with GABARAP is
strikingly distinct in the absence and presence of the γ2(381–403)
competitor peptide (Fig. 4, [2]).
Sequence alignments of the MA helices of the various ligand-gated
ion channels reveal little (cation channels [42]) or no homology
Fig. 3. Structural insights into the MA helical domain. A and B: Electron microscopic images of negatively stained tubular arrays of the nicotinic acetylcholine receptor viewed in
transverse sections. A. The distribution of the protein components that comprise the ion channel spans both sides of the lipid bilayer. The arrow indicates the extracellular mouth of
the channel throughwhich ions permeate. The star indicates the intracellular gondola domain formed by the ﬁveMA helices, which overlies the axial path of the channel beneath the
lipid bilayer. Its position implies that ions must also permeate this structure. B. Equivalent images of tubes frozen in alkaline solution (pH 11) cause the gondola domain to
redistribute in an irregular way over the cytoplasmic surface while the transmembrane and extracellular ligand-binding domain retained their position in the crystal lattice (images
courtesy of N Unwin). C. NMR structure of the GABAA γ381–403 MA peptide. In solution the peptide shows a propensity to adopt an α-helical structure. The structure reveals a
positively charged helical face dominated by 3 arginine residues (R) and a relatively more extended structure where the critical 5N-terminal residues lie (CFEDC).
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regions share an amphipathic nature and at a structural level they are
predicted to form an α-helix. What is not clear at this point in time is
whether the GABAA receptor is the only member of this family able to
undergo transitions to high conductance states via the formation of
intermolecular protein–protein interactions involving the conserved
MA helices.
Conductance levels of ligand-gated ion channels do vary, which
are inﬂuenced in part by the expression system (e.g., oocytes vs.
mammalian vs. native receptors (e.g., nAChR [45], glycine receptor
[46,47]). The maximum single-channel conductance level recorded
for recombinant, clustered GABAA channels achieved by drug
potentiation is approximately 70 pS (c/a patch αβγ2S+GABARAP;
[17]) whereas native GABAA channels have been recorded in excess of
90 pS [16]. Interestingly, some members of the ligand-gated ion
channel family are able to achieve similar high conductance levels
when expressed in heterologous systems and do not require any
exogenous facilitator protein. For example, the recombinantly
expressed heteromeric Torpedo californica acetylcholine receptor
(α2βγδ) [48] and homomeric α1 glycine receptors [40] exhibit
conductances as high as 87 and 92 pS, respectively. On the basis of
structural and functional conservation within the ligand-gated ion
channel family it is possible therefore, that all members have the
potential to conduct ions in this highly permissive fashion but some
need to be potentiated in order to do so. Hence the MA helices mayFig. 4. Model depicting protein–protein interactions between adjacent GABAA receptors tha
channels. It is postulated that trafﬁcking of GABAA receptors by GABARAP facilitates interact
the potential to alter the disposition of the gondola structure beneath the pore, which, in th
reduced steric hindrance. In contrast, the unregulated expression of GABAA receptors pr
interactions. These channels exhibit unitary conductance levels and drugs increase only the o
model illustrate the large difference in current size between clustered and non-clustered GA
variations in physiological responses. C=closed, O=open.function as regulatory domains in the various members that, by
participating in protein–protein, or protein–lipid interactions and/ or
by undergoing post-translational modiﬁcations, have the potential to
make conductance sensitive to intracellular regulation.
2.4. Drug-induced conformational states in clustered GABAA receptors
Drugs acting at GABAA receptors increase the inhibitory current by
increasing the open probability of the channel. Classically the
biophysical properties of the ion channel reﬂecting this change
included increases in channel open times, decreases in closed times
and an increase in the frequency of opening (e.g., prolonged bursting
and the opening of additional channels) [10–13,34,35,49]. In clustered
GABAA receptors the single-channel conductance is also increased and
there is a strong correlation between higher conductances and longer
mean open times [18,19]. Little is known of the mechanism through
which drug potentiation confers any of these properties on the ion
channel. In high conductance GABAA channels where the GABA
current was potentiated by diazepam, sub-maximal conductance
states (substates) appear following the application of the γ2 MA
peptide (in the continued presence of drug) (Fig. 2B–D). This
observation suggests that substate activity of the channel arises
from conformational changes in the conserved MA helices that
comprise the gondola structure. By extension, it also implies that
drugs must facilitate the movement of such a structure in the GABAAt enable receptor cross-talk, facilitating the enhanced biophysical properties of the ion
ions between γ-subunit intracellular loops of adjacent receptors. Drug binding provides
ese clustered receptors increases ion permeation through each channel because of the
oduces dispersed receptors in the plasma membrane, which lack the inter-receptor
pen probability of the channel(s). Single-channel traces depicted beneath each receptor
BAA receptors, which is likely to impose functional differences in cellular signaling and
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GABAA receptors such a model requires that all potentiator binding
events effect a common conformational change in the channel
structure, which we suggest is the movement of the gondola domain.
How this movement of an intracellular domain is co-ordinated with
gating conformational changes occurring in the pore domain have yet
to be examined.
A study involving mutations in a motif identiﬁed within the
conserved extracellular cystine loop (Cys loop) of subunits in the
GABAA receptor (aromatic, proline, aliphatic sequence, ArProAl motif)
provides some clues as to how the binding of potentiators could
provide the additional free energy to drive such a process in the
gondola domain [50]. The conserved extracellular Cys loop of the
different subunits in the αβγ2S GABAA receptor was seen to
participate asymmetrically in agonist activation (α and β Cys loops)
and drugmodulation (γ andα Cys loops).While all acted equivalently
to resist gating-dependant conformational changes it was the
potentiation by drugs (and presumably endogenous potentiators)
that recruited the single γ-subunit into the activation process thereby
channelling additional ligand-binding energy into driving the gating-
dependant conformational changes and rendering the activation
process pseudo-symmetrical [50]. Interestingly, all the different
classes of drugs tested in the study acted similarly to affect
potentiation (benzodiazepines, barbiturates and general anaes-
thetics). A common theme linking drug potentiation in themutational
study of the conserved extracellular Cys loop and that describing the
existence of protein–protein interactions involving the conserved
cytoplasmic MA helices is the critical involvement of the γ-subunit in
both these molecular events. Thus drug potentiation could be viewed
as arising from the additional energy required to shift the impediment
to ion ﬂow provided by the gondola structure.
Drugs do not signiﬁcantly increase the conductance level of
dispersely expressed recombinant GABAA receptors [2,17]. However,
irrespective of composition, recombinant receptors do exhibit
multiple conductance states, a main state and a substate, approxi-
mately 30 and 22 pS, respectively [34,35,49]. What drugs do inﬂuence
under these conditions is the proportion of time that the channel
spends in these states, shifting the equilibrium signiﬁcantly towards
the main, longer-lived conductance state [34,35]. How an individual
GABAA channel achieves this subtle variation in conductance is not
known. In light of the results with high conductance GABAA channels
and competitive MA peptides, it is possible that drugs similarly
facilitate and stabilise movements in the gondola domain of these
unclustered receptors; however, the structural perturbations are
smaller and consequently the increased permissiveness to ions is less.
Alternatively, the conformation of the gondola domain that gives rise
to high conductance states is less stable in unclustered receptors and
simply not occupied with any great probability.
3. Conductance properties of ion channels in general
Ligand-gated ion channels are but one class of ion channel. That its
members show a wide range of conductance levels is not unique to
this class. Potassium channels form a large diverse family of channels
and its members also show variation in their conductance properties.
A recent X-ray crystallographic study of inward rectiﬁer channels
from bacteria (KirBac channels) has provided the ﬁrst structural
evidence for conformational changes in an intracellular domain
correlating with ion conduction at the selectivity ﬁlter, some 20 Å
away in the membrane [44]. Such a study highlights the existence of
multiple ‘gates,’ all of which have the potential to inﬂuence ion
permeation and that such gates can be remote from the constriction. It
is interesting to note that the single-channel records of wild-type
KirBac channels share a remarkable similarity to those of GABAA
channels. For example, both the potassium and the GABAA channels
exhibit high conductance states (N40 pS) as well as multiple lowerconductance states. It will be of interest to see whether the
conductance state transitions of the KirBac channel correlate with
conformational changes in the cytoplasmic domain and indeed how
the binding of modulators to this domain, regulate ion permeation.
4. Concluding remarks
It is generally accepted that the considerable potential of the brain
to diversify its inhibitory response is endowed through the activation
of an array of GABAA receptors, distinct in their subunit composition,
subcellular location and brain region distribution [22,51,52]. The
discovery that intermolecular protein interactions dramatically alter
GABAA ion channel properties suggests that the interaction status of
the receptor may represent another level of intracellular regulation
which, potentially, could be effective on a much faster time scale than
changes effected by differential expression of receptor subunits. As
the ﬁeld of ligand-gated ion channels emerges from studying an
individual ion channel to that of its signaling complexes one can begin
to appreciate how the ability of such macromolecular complexes to
respond is dependent upon the compliment of proteins associated in
the complex. The dynamic exchange of protein interaction partners
would provide the brain with an enormous capacity to adapt and
respond to environmental stimuli.
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